14-3-3 proteins are required for hippocampal long-term potentiation and associative learning and memory

Journal of Neuroscience

Volumn 34, Issue 14, 2014, Pages 4801-4808

  Qiao, Haifa ^a,b   Foote, Molly ^a   Graham, Kourtney ^a   Wu, Yuying ^a   Zhou, Yi ^a  

^a FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

14 3 3 proteins; Fear conditioning; Long term potentiation; NMDA receptors; Passive avoidance

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN 14 3 3;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGICAL PROCEDURES; ELECTROPHYSIOLOGY; EXPERIMENTAL BEHAVIORAL TEST; GENE INACTIVATION; HIPPOCAMPUS POTENTIAL; LONG TERM POTENTIATION; MALE; MEMORY; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL; STATE DEPENDENT LEARNING; SYNAPSE; TRANSGENIC MOUSE; WESTERN BLOTTING; WHOLE CELL PATCH CLAMP;

14-3-3 PROTEINS; FEAR CONDITIONING; LONG-TERM POTENTIATION; NMDA RECEPTORS; PASSIVE AVOIDANCE;

14-3-3 PROTEINS; ANIMALS; ASSOCIATION LEARNING; AVOIDANCE LEARNING; BACTERIAL PROTEINS; CONDITIONING (PSYCHOLOGY); ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; FEAR; HIPPOCAMPUS; LONG-TERM POTENTIATION; LUMINESCENT PROTEINS; MEMORY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PATCH-CLAMP TECHNIQUES;

EID: 84899431011     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4393-13.2014     Document Type: Article

References (47)

1. Bannerman DM, Bus T, Taylor A, Sanderson DJ, Schwarz I, Jensen V, Hvalby O, Rawlins JN, Seeburg PH, Sprengel R (2012) Dissecting spatial knowledge from spatial choice by hippocampal NMDA receptor deletion. Nat Neurosci 15:1153-1159.CrossRef Medline
2. Berg D, Holzmann C, Riess O (2003) 14-3-3 proteins in the nervous system. Nat Rev Neurosci 4:752-762.CrossRef Medline
3. Broadie K, Rushton E, Skoulakis EM, Davis RL (1997) Leonardo, a Drosophila 14-3-3 protein involved in learning, regulates presynaptic function. Neuron 19:391-402.CrossRef Medline
4. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868.CrossRef Medline
5. Cao W, Yang X, Zhou J, Teng Z, Cao L, Zhang X, Fei Z (2010) Targeting 14-3-3 protein, difopein induces apoptosis of human glioma cells and suppresses tumor growth in mice. Apoptosis 15:230-241.CrossRef Medline
6. Caroni P (1997) Overexpression of growth-associated proteins in the neurons of adult transgenic mice. J Neurosci Methods 71:3-9.CrossRef Medline
7. Cheah PS, Ramshaw HS, Thomas PQ, Toyo-Oka K, Xu X, Martin S, Coyle P, Guthridge MA, Stomski F, van den Buuse M, Wynshaw-Boris A, Lopez AF, Schwarz QP (2012) Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3zeta deficiency. Mol Psychiatry 17:451-466.CrossRef Medline
8. Chen BS, Roche KW (2009) Growth factor-dependent trafficking of cerebellar NMDA receptors via protein kinase B/Akt phosphorylation of NR2C. Neuron 62:471-478.CrossRef Medline
9. Fantl WJ, Muslin AJ, Kikuchi A, Martin JA, MacNicol AM, Gross RW, Williams LT (1994) Activation of Raf-1 by 14-3-3 proteins. Nature 371: 612-614.CrossRef Medline
10. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28:41-51.CrossRef Medline
11. Foote M, Zhou Y (2012) 14-3-3 proteins in neurological disorders. Int J Biochem Mol Biol 3:152-164. Medline
12. Groc L, Choquet D (2006) AMPA and NMDA glutamate receptor trafficking: multiple roads for reaching and leaving the synapse. Cell Tissue Res 326:423-438.CrossRef Medline
13. Hallett PJ, Collins TL, Standaert DG, Dunah AW (2008) Biochemical fractionation of brain tissue for studies of receptor distribution and trafficking. Curr Protoc Neurosci 42:1.1611-1616.CrossRef Medline
14. Hausser A, Storz P, Link G, Stoll H, Liu YC, Altman A, Pfizenmaier K, Johannes FJ (1999) Protein kinase C mu is negatively regulated by 14-3-3 signal transduction proteins. J Biol Chem 274:9258-9264. Medline
15. Ikeda M, Hikita T, Taya S, Uraguchi-Asaki J, Toyo-oka K, Wynshaw-Boris A, Ujike H, Inada T, Takao K, Miyakawa T, Ozaki N, Kaibuchi K, Iwata N (2008) Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. Hum Mol Genet 17:3212-3222.CrossRef Medline
16. Kaeser PS, Kwon HB, Blundell J, Chevaleyre V, Morishita W, Malenka RC, Powell CM, Castillo PE, Südhof TC (2008) RIM1alpha phosphorylation at serine-413 by protein kinase A is not required for presynaptic longterm plasticity or learning. Proc Natl Acad Sci U S A 105:14680-14685.CrossRef Medline
17. Kim JJ, Jung MW (2006) Neural circuits and mechanisms involved in Pavlovian fear conditioning: a critical review. Neurosci Biobehav Rev 30: 188-202.CrossRef Medline
18. Lau CG, Zukin RS (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8:413-426.CrossRef Medline
19. Li Y, Wu Y, Zhou Y (2006) Modulation of inactivation properties of CaV2.2 channels by 14-3-3 proteins. Neuron 51:755-771.CrossRef Medline
20. Martin H, Rostas J, Patel Y, Aitken A (1994) Subcellular localisation of 14- 3-3 isoforms in rat brain using specific antibodies. J Neurochem 63:2259-2265.CrossRef Medline
21. Martin SJ, Grimwood PD, Morris RG (2000) Synaptic plasticity and memory: an evaluation of the hypothesis. Ann Rev Neurosci 23:649-711.CrossRef Medline
22. Masters SC, Fu H (2001) 14-3-3 proteins mediate an essential antiapoptotic signal. J Biol Chem 276:45193-45200.CrossRef Medline
23. Moore BEP, VJ (1967) Specific acidic proteins of the nervous system. In: Physiological and biochemical aspects of nervous integration (FD Carlson, ed), pp 343-359. Englewood Cliffs, NJ: Prentice Hall.
24. Morris RG, Anderson E, Lynch GS, Baudry M (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-Daspartate receptor antagonist, AP5. Nature 319:774-776.CrossRef Medline
25. Muslin AJ, Tanner JW, Allen PM, Shaw AS (1996) Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84:889-897.CrossRef Medline
26. Obsil T, Obsilova V (2011) Structural basis of 14-3-3 protein functions. Semin Cell Dev Biol 22:663-672.CrossRef Medline
27. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H (1997) Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277:1501-1505.CrossRef Medline
28. Pittenger C, Fasano S, Mazzocchi-Jones D, Dunnett SB, Kandel ER, Brambilla R (2006) Impaired bidirectional synaptic plasticity and procedural memory formation in striatum-specific cAMP response element-binding protein-deficient mice. J Neurosci 26:2808-2813.CrossRef Medline
29. Ramsey AJ, Milenkovic M, Oliveira AF, Escobedo-Lozoya Y, Seshadri S, Salahpour A, Sawa A, Yasuda R, Caron MG (2011) Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner. Proc Natl Acad Sci U S A 108:5795-5800.CrossRef Medline
30. Schmeisser MJ, Ey E, Wegener S, Bockmann J, Stempel AV, Kuebler A, Janssen AL, Udvardi PT, Shiban E, Spilker C, Balschun D, Skryabin BV, Dieck St, Smalla KH, Montag D, Leblond CS, Faure P, Torquet N, Le Sourd AM, Toro R, et al (2012) Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486:256-260.CrossRef Medline
31. Shirao T, Sekino Y (2001) Clustering and anchoring mechanisms of molecular constituents of postsynaptic scaffolds in dendritic spines. Neurosci Res 40:1-7.CrossRef Medline
32. Simsek-Duran F, Linden DJ, Lonart G (2004) Adapter protein 14-3-3 is required for a presynaptic form of LTP in the cerebellum. Nat Neurosci 7:1296-1298.CrossRef Medline
33. Skoulakis EM, Davis RL (1996) Olfactory learning deficits in mutants for leonardo, a Drosophila gene encoding a 14-3-3 protein. Neuron 17:931-944.CrossRef Medline
34. Skoulakis EM, Davis RL (1998) 14-3-3 proteins in neuronal development and function. Molecular neurobiology 16:269-284. Medline
35. Steinacker P, Schwarz P, Reim K, Brechlin P, Jahn O, Kratzin H, Aitken A, Wiltfang J, Aguzzi A, Bahn E, Baxter HC, Brose N, Otto M (2005) Unchanged survival rates of 14-3-3gamma knock-out mice after inoculation with pathological prion protein. Mol Cell Biol 25:1339-1346.CrossRef Medline
36. Toyooka K, Muratake T, Tanaka T, Igarashi S, Watanabe H, Takeuchi H, Hayashi S, Maeda M, Takahashi M, Tsuji S, Kumanishi T, Takahashi Y (1999) 14-3-3 protein η chain gene (YWHAH) polymorphism and its genetic association with schizophrenia. Am J Med Genet 88:164-167.CrossRef Medline
37. Toyo-oka K, Shionoya A, Gambello MJ, Cardoso C, Leventer R, Ward HL, Ayala R, Tsai LH, Dobyns W, Ledbetter D, Hirotsune S, Wynshaw-Boris A (2003) 14-3-3ε is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome. Nat Genet 34:274-285.CrossRef Medline
38. Tsien JZ, Huerta PT, Tonegawa S (1996) The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87:1327-1338.CrossRef Medline
39. VanGuilder HD, Farley JA, Yan H, Van Kirk CA, Mitschelen M, Sonntag WE, FreemanWM (2011) Hippocampal dysregulation of synaptic plasticityassociated proteins with age-related cognitive decline. Neurobiol Dis 43: 201-212.CrossRef Medline
40. Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood WH 3rd, Donovan DM, Webster M, Freed WJ, Becker KG (2001) Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 55:641-650.CrossRef Medline
41. Wang B, Yang H, Liu YC, Jelinek T, Zhang L, Ruoslahti E, Fu H (1999) Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. Biochemistry 38:12499-12504.CrossRef Medline
42. Won H, Lee HR, Gee HY, Mah W, Kim JI, Lee J, Ha S, Chung C, Jung ES, Cho YS, Park SG, Lee JS, Lee K, Kim D, Bae YC, Kaang BK, Lee MG, Kim E (2012) Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486:261-265.CrossRef Medline
43. Wong AH, Macciardi F, Klempan T, Kawczynski W, Barr CL, Lakatoo S, Wong M, Buckle C, Trakalo J, Boffa E, Oak J, Azevedo MH, Dourado A, Coelho I, Macedo A, Vicente A, Valente J, Ferreira CP, Pato MT, Pato CN, et al (2003) Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3eta gene. Mol Psychiatry 8:156-166CrossRef Medline
44. Wong AH, Likhodi O, Trakalo J, Yusuf M, Sinha A, Pato CN, Pato MT, Van Tol HH, Kennedy JL (2005) Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder. Schizophr Res 78: 137-146.CrossRef Medline
45. Yang Y, Calakos N (2010) Acute in vivo genetic rescue demonstrates that phosphorylation of RIM1alpha serine 413 is not required for mossy fiber long-term potentiation. J Neurosci 30:2542-2546.CrossRef Medline
46. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87:619-628.CrossRef Medline
47. Zhou Y, Schopperle WM, Murrey H, Jaramillo A, Dagan D, Griffith LC, Levitan IB (1999) A dynamically regulated 14-3-3, slob, and slowpoke potassium channel complex in Drosophila presynaptic nerve terminals. Neuron 22:809-818.CrossRef Medline